Bayer Weimar GmbH und Co. KG, Weimar, Germany – FDA Inspections

Inspection records and compliance data for Bayer Weimar GmbH und Co. KG in Weimar. 5 FDA inspections on record, 1 Form 483, last inspected November 24, 2022.

Company Profile

This profile covers Bayer Weimar GmbH und Co. KG based in Weimar, Germany.

FDA Inspection History

FDA inspections: 5
OAI: 0
VAI: 3
NAI: 2
Form 483s: 1
Warning letters: 0

First inspected December 4, 2009. Last inspected November 24, 2022.

Most cited issue areas

Establish reliability of supplier's C of A1 inspection
Establish reliability of supplier"s C of A1 inspection
Extent of discrepancy, failure investigations1 inspection

FDA inspections (5)

Date	Result	FDA center(s)	Insp. #
November 24, 2022	VAI	Human Drugs · Drug Quality Assurance	1274501
September 13, 2019	VAI	Human Drugs · Drug Quality Assurance	1101920
November 5, 2015	NAI	Human Drugs · Drug Quality Assurance	948310
October 19, 2012	NAI	Human Drugs · Drug Quality Assurance	805216
December 4, 2009	VAI	Human Drugs · Drug Quality Assurance	636510

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

BIPSO GmbH

Aesica Pharmaceuticals GmbH

Glatt Pharmaceutical Services GmbH & Co. KG

Fidelio Healthcare Limburg GmbH

Astellas Ireland Co Ltd

SGS Quay Pharmaceuticals Limited

Beijing Sciecure Pharmaceutical Co Ltd

Novo Nordisk Production Ireland Limited

MSD International GmbH (Singapore Branch)

Novartis Farma S.P.A.